ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000271.1|Spore_1 # 1 # 510 # -1 # ID=1_1;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.686	BGC0000271.1|Spore_1 	1	510	-	Loose	210	48.521	Escherichia coli AcrAB-TolC with MarR mutations conferring resistance to ciprofloxacin and tetracycline	30.59	3003378	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic target alteration; antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGCCGAAGCCCCTCAGTCTCGCCTTCGATCCCATCGCGCGCGCCGACGAACACTGGAAGCAGCGCTGGGGAAACGTGCCGTCCATGGCCGCGATCACCTCGATCATGCGCGCGCACCAGATTCTGCTGGCGGAGGTCGACGCGGTCGTCAAGCCGTACGGGCTGACCTTCGCGCGGTACGAGGCGCTGGTGCTGCTCACCTTCTCCAAGGCGGGCGAGCTGCCGATGTCCAAGATCGGCGAGCGGTTGATGGTGCACCCGACGTCCGTCACCAACACCGTGGACCGGCTGGTGACGTCCGGGCTCGTCGACAAGCGCCCCAACCCGAACGACGGGCGCGGAACCCTCGCCTCGATCACCGACAAGGGCCGCGAGGTCTGCGACGCGGCGACCCGCGACCTGATGGCGATGGACTTCGGGCTCGGTGCCTACGACGGGGAGGAGTGCGCGGAGATCTTCGCGATGCTGCGCCCGCTGCGCATCGCCGCGCACGACTTCGACGAGGAGTAG	VPKPLSLAFDPIARADEHWKQRWGNVPSMAAITSIMRAHQILLAEVDAVVKPYGLTFARYEALVLLTFSKAGELPMSKIGERLMVHPTSVTNTVDRLVTSGLVDKRPNPNDGRGTLASITDKGREVCDAATRDLMAMDFGLGAYDGEECAEIFAMLRPLRIAAHDFDEE	MKSTSDLFNEIIPLGRLIHMVNQKKDRLLNEYLSPLDITAAQFKVLCSIRCAACITPVELKKVLSVDLGALTRMLDRLVCKGWVERLPNPNDKRGVLVKLTTGGAAICEQCHQLVGQDLHQELTKNLTADEVATLEYLLKKVLP	117.36	gnl|BL_ORD_ID|1984|hsp_num:0	431			84	333	tigecycline; ciprofloxacin; tetracycline; rifampin; chloramphenicol; ampicillin; cefalotin; triclosan
BGC0000271.1|Spore_2 # 760 # 2403 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.716	BGC0000271.1|Spore_2 	760	2403	-	Loose	550	119.398	Nocardia farcinica rox	32.6	3007210	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGAACGAAGAAGTCGACCACCACGTGCCGGTTCTCATCGTGGGGGGATCCCTGGTGGGTCTGTCCGCCTCGCTGTTCCTCGGCCGGCTCGGCATCCCGCACATGCTGGTCGAGAAACACGCGGGCACCTCGAAGCACCCGCGTGGGCGCGGGAACAACGTGCGCACGATGGAGCTGTTCCGGGTGGCCGGGGCCGAACAAGCGATCCGCAAGGCCGCGTCGACCCTGGCGGACAACCACGGCATCCTGCAGACCTCGTCCCTGACCGACGACGAGGGCGAGTGGCTGTTCAAGGAGATCGACCCGGGTGGCGGCCTGGCCCGCTTCAGCCCGAGCGGATGGTGTCTGTGCAGTCAGAACGACCTGGAGCCGGTGCTGCTGAAGTCCGCCCGCGGCCTCGGGGGCGACATCCGGTTCTCCACCGAGATGCTCTCCTTCGACCAGGACGCGGAGGGCGTCACCGCGCTCATGAAGAACCGGGACACCGGCGCGCACACCACGGTGCGGGCGGAGTACCTCATCGCGGCCGACGGGCCGCGCAGCCCGGTCCGCGAGCGCCTGGGCATCCGCCAGACGGGCCCCGGAGACCTGTTCCACAACGTGAGCATCACCTTCAACTCCCGCGCACTCGCGGACGCGGTGGGCGACCGGCGCTTCATCTGCTGCTACCTGACGAACCCGGAGGCGGACGGCGCGCTCCTGCCCGTGGACAACGTGGAGAAGTGGGTGTTCCACGCTCCCTGGCACCCCGAGCAGGGCGAGACGCTGGAGGACTTCACCGACGAGCGGTGCGTCTCCCACATCCGCCGGGCCGTCGGTGATCTCGACATGGACGTCGAGATCACCGGCAGGGCGCCCTGGCACGCGGCGGAGCGGGTCGCCGAGCGGTACGCGTCGGAACGGGTCTTCCTCGCCGGGGACTCCGCCCACGAGATGTCGCCGACCGGGGCGTTCGGCTCCAACACCGGTATCCAGGACGCACACAACCTCGCCTGGAAGCTCGCCGCCGTACTGAACGGGTGGGCCGGGCCCGGGCTGCTCCAGTCCTACGAGGCCGAGCGTCTCCCAGTGGCGCAGGCGACGAGCGCGCGGGCCTCGGCCCGTTCCGCGGAACACAGCCATCCGGGCTACGCCCCCGCTCCCGGCGCGGGCGGCGGTGGCGGCGGACGTCAGGGCGGTGTCCTCAAGGTGGCCCTGGGCTACCGCTATCCGCGTGGCGCCGTCATCGGCGCCGACCCGGCGGGCCCGGTCGTGCCCGAGCAGATGGCCATGGCCGGCGAACCCGGCAGCCGCGCCCCGCACATGTGGCTCCTGCGCTCCGGCGCCCGCACCTCCACGCTCGATCTGTACGAGCGCTCGTTCGTCCTGCTCAGCGGGGCTGCCGAGGACGCCTGGCACCGGGCGGCGACCAGCGTTGCCGAGCGCCTCGCCGTAAGCCTCGACTCGTACCGCATCGGCAAGGACCCGCACGCCGAGCTCGTCCCCGAGAACGGCACGGACTGGGCCGAACTCCACGGCACGACGCCGCGGGGCGCGGTGCTGGTGCGGCCCGACGGGTATGTGGCGTGGCGGTCCGAGGGCCCGCTGGCCGAACCGGAGGCGACGCTGTACGAGATCATGGCCTCCCTGCTGGACCTGGCCTGA	MNEEVDHHVPVLIVGGSLVGLSASLFLGRLGIPHMLVEKHAGTSKHPRGRGNNVRTMELFRVAGAEQAIRKAASTLADNHGILQTSSLTDDEGEWLFKEIDPGGGLARFSPSGWCLCSQNDLEPVLLKSARGLGGDIRFSTEMLSFDQDAEGVTALMKNRDTGAHTTVRAEYLIAADGPRSPVRERLGIRQTGPGDLFHNVSITFNSRALADAVGDRRFICCYLTNPEADGALLPVDNVEKWVFHAPWHPEQGETLEDFTDERCVSHIRRAVGDLDMDVEITGRAPWHAAERVAERYASERVFLAGDSAHEMSPTGAFGSNTGIQDAHNLAWKLAAVLNGWAGPGLLQSYEAERLPVAQATSARASARSAEHSHPGYAPAPGAGGGGGGRQGGVLKVALGYRYPRGAVIGADPAGPVVPEQMAMAGEPGSRAPHMWLLRSGARTSTLDLYERSFVLLSGAAEDAWHRAATSVAERLAVSLDSYRIGKDPHAELVPENGTDWAELHGTTPRGAVLVRPDGYVAWRSEGPLAEPEATLYEIMASLLDLA	MIDVIIAGGGPTGLMLAGELRLHGVRTVVLEKEPTPNQHSRSRGLHARSIEVMDQRGLLERFLAHGEQFRVGGFFAGLAAEWPADLDTAHSYVLAIPQVVTERLLTEHATELGAEIRRGCEVAGLDQDADGVTAELADGTRLRARYLVGCDGGRSTVRRLLGVDFPGEPTRVETLLADVRIDVPVETLTAVVAEVRKTQLRFGAVPAGDGFFRLIVPAQGLSADRAAPTLDELKRCLHATAGTDFGVHSPRWLSRFGDATRLAERYRTGRVLLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAAIGGWAPPDLLDSYHDERHPVAAEVLDNTRAQMTLLSLDPGPRAVRRLMAELVEFPDVNRHLIEKITAIAVRYDLGDGHDLVGRRLRDIPLTEGRLYERMRGGRGLLLDRTGRLSVSGWSDRVDHLADPGAALDVPAALLRPDGHVAWVGEDQDDLLAHLPRWFGAAT	115.64	gnl|BL_ORD_ID|4834|hsp_num:0	5821			3	981	rifampin
BGC0000271.1|Spore_3 # 2756 # 3880 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=AGGAG/GGAGG;rbs_spacer=11-12bp;gc_cont=0.693	BGC0000271.1|Spore_3 	2756	3880	+	Loose	500	33.113	fexA	31.46	3002704	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGACAACTTCGGAACGTGTATCGCAGTCCGCGTTCGACGGCTCCCGGCTGCGGGTCGTCCTGCTGCTGGACCTCCATGACGGCGCCCAGAAGCAGTTCCTGGAGGCCTACGAACAACTGCGCAACCAAGTGGCCTCCGTGCCGGGCCACATCAGCGACCAGCTGTGCCAGTCGATCGAGAATCCCTCGCAGTGGCTCATCACCAGCGAGTGGGAGAGCGCCCCGCCCTTCCTGGCGTGGGTGAACAGCGAGGAACACGTCGAGACGGTCCAGCCGCTGCACAGCTGCGTCCGGGACACGCGGTCCCTGCGCTTCAGCGTTCTGCGCGAGACGGGGAACATCTCCGCGCCGCTCCCCCAGTCGGAGAAGGGCCGCCTCCAGGCGACGGCACGGGTGGGCGACGGCGTCGTGCGCCACGCCCTCACCTTCACCGTGAAGCCGGGCAGCGAGCCGATGGTCGCCAAGATCCTCGCCGGATACTCCTCGCCGCAGGCGCAGGTCGACGAGAACACCCGACTGCGCCGCACCTCGCTCTTCATGCACGGCAACCGGGTGGTACGCGCCATCGAGGTGGAAGGCGACCTGATGGCCGCCCTGCGCCATGTGTCCCGGCAGCCCGAGGTCATGGCGGTCGAGGAGGCCATCAACCCCTATCTGGAGCAGGACCGGGACCTCAGCGATCCGGGATCGGCCCGGGTCTTCTTCACCCGGGCGGCGCTGCCCGCGGTGCACCATGTGTCGGTCGGCACCGGCGAGCCGTCGGACGTGGAGCGGCACGCGCTGTTCTACCCGGCCAAGAGCGGGTCCGGCATGGCCCTGGCCCGGCTGCTCGCCCGCGAGGACGAGGCGGCGGCCGACGACCCCGCCAACCCCATCCACTGCAGCACCATCTTCCAGCGCGACGACATCGTGGTCCGTCTGGTCGATGTGCGGGGCAGCATCGAGGACGACCCCGTCCTGGCCCTCGGTCTCAAGGGCGACCGCAACGGCGCGGTCCTGTCCCGCCTGCTCGACGCCGACGCGCTCGGCGTCGACGGTGCGCCGACGACCGAGAAGGAGATCTCGCGCTTCCTCGAGCGGTCCGACATGCAACTGATCACCGACCGCAGCTCATCAGCCTCCTGA	MTTSERVSQSAFDGSRLRVVLLLDLHDGAQKQFLEAYEQLRNQVASVPGHISDQLCQSIENPSQWLITSEWESAPPFLAWVNSEEHVETVQPLHSCVRDTRSLRFSVLRETGNISAPLPQSEKGRLQATARVGDGVVRHALTFTVKPGSEPMVAKILAGYSSPQAQVDENTRLRRTSLFMHGNRVVRAIEVEGDLMAALRHVSRQPEVMAVEEAINPYLEQDRDLSDPGSARVFFTRAALPAVHHVSVGTGEPSDVERHALFYPAKSGSGMALARLLAREDEAAADDPANPIHCSTIFQRDDIVVRLVDVRGSIEDDPVLALGLKGDRNGAVLSRLLDADALGVDGAPTTEKEISRFLERSDMQLITDRSSSAS	MKKDSKSKEMIQSEKRGSTRLLMMVLSLSVLVGAITADLVNPVLPLISKDLEASKSQVSWIVSGIALVLAIGVPIYGRISDFFELRKLYIFAIMILASGSLLCAIAPNLPLLVLGRMVQGAGMSAIPVLSIIAISKVFPQGKRGGALGIIAGSIGVGTAAGPIFGGVVGQYLGWNALFWFTFLLAIMIVIGAYYALPTIKPAESVGSNKNFDFIGGLFLGLTVGLLLFGITQGETSGFSSFSSLTSLIGSVVALVGFIWRIVTAENPFVPPVLFNNKDYVNTVIIAFFSMFAYFAVLVFVPLLVVEVNGLSSGQAGMILLPGGVAVAILSPFVGRLSDRFGDKRLIITGMTLMGLSTLFLSTYASGASPLLVSVGVLGVGIAFAFTNSPANNAAVSALDADKVGVGMGIFQGALYLGAGTGAGMIGALLSARRDATEPINPLYILDAMSYSDAFLAATGAILIALIAGLGLKKRG	78.74	gnl|BL_ORD_ID|835|hsp_num:0	907			1173	1416	chloramphenicol; florfenicol
BGC0000271.1|Spore_4 # 3954 # 4397 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.691	BGC0000271.1|Spore_4 	3954	4397	+	Loose	525	25.409	LRA-1	50.0	3002482	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	class A LRA beta-lactamase	ATGACCACGCCCCGCCCACGCATCGTGGACCTCAGCGAGACCGAGCCCAACACCAGGCGCGGAGGTGATCTGCGCGCCATGCTCACGCCCACCGCGGTGGGCGCCAAGAGCGGCTTCATGGGCCTCGCCATCGTGCAGCCCGGCGAACGCATCGGCGAGCACTACCACCCGTACTCCGAGGAGTTCGTCTACGTCGTGAGCGGTCGGCTCGAAGTCGACCTGGACGGCGAGACGCACCCGATCCAGCCCGACCAGGGCCTGCTGATTCCCATCAACATGCGGCACCGCTTCCGCAACGTGGGCGACGTGGAGGCCCGCATGGTCTTCCACCTGGGCCCGCTGGCGCCGCGCCCCAAGCTCGGCCACGTCGACACCGAGGAGACCGACGGCCTGGAGGGAGCCGGACAGGCGATGACACCACAGCGAACCGAGGCCGTGTCATGA	MTTPRPRIVDLSETEPNTRRGGDLRAMLTPTAVGAKSGFMGLAIVQPGERIGEHYHPYSEEFVYVVSGRLEVDLDGETHPIQPDQGLLIPINMRHRFRNVGDVEARMVFHLGPLAPRPKLGHVDTEETDGLEGAGQAMTPQRTEAVS	MNPPIHRRTLLLAASVLPLASACTAWSAKGPQQDASAQLAALEAASGSRLGVVGFNTATGARVQHRAEERFPFCSTFKLMLAAAVLERSAKEGDLLARRVNYSKGDLVSYSPITEKNVATGMTVAELCAATVQYSDNGAANLLMKILGGPSAVTAFARASGDEVFRLDRWETELNTAIPGDLRDTTTPAAMAASVQRLVLGNALGAAQREQLKTWLLGNTTSTQRFLAGVPAGWKVGDKTGSGSYGTTNDVGVLWPPAGAPLVLAVYLTFPQKEAKGRSDVVASATRIAVSALAS	49.83	gnl|BL_ORD_ID|1464|hsp_num:0	1601			498	582	
BGC0000271.1|Spore_6 # 5659 # 6909 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.728	BGC0000271.1|Spore_6 	5659	6909	+	Loose	750	103.219	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	33.12	3003463	protein variant model	F413L	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	ATGAAGCCGCAGCAAAAACGGCGTGCCGCCATCACCGGCATAGGCGTCGTCGCCCCCAACGGACTGAGCACCGAGACCTTCTGGAAGTCCACCGAGAAGGGCCTCTGTGTACTGGACCGGGTGACCCGCGAGGGGTGCGACCATCTGCCCCTGCGGATCGCCGGCGAGGTCCGCGGATTCGACCCGGTGGCGCTGATCGAGGAGCGGTTCCTCGTCCAGACCGACCGGTTCACCCACTTCGCGATGGCCGCCGCCGACCTCGCCCTGGAGGACGCCCGGCTCGGCCGCACCTACACCGGCGACGAGCCGTTCGGGATCGGCGTGGTCACCGCCGCGGGGTCCGGCGGCGGCGAGTTCGGGCAGCGCGAACTGCAGCGGCTGTGGGGACAGGGGCCCAGATTCGTGGGCCCGTACCAGTCCATCGCCTGGTTCTACGCGGCCAGCACCGGCCAGATCTCCATCAGGGGCGGCTTCAAGGGACCGTGCGGCGTCGTGGCCAGCGACGAGGCCGGCGGTCTGGACGCCCTGGCGCACGCCGCCCGAGCCGTCCGGCGCGGCACCGACGTGGTCGTGGCCGGTGCCGCCGAGGCTCCGCTGGCTCCGTATTCGATGGTCTGCCAGCTCGGCTACGAGGACCTCAGCACCAGCGACGACCCGGCCTGCGCCTACCGGCCCTTCACCGGCGCTGCCTGCGGATTCGTGCCCGCCGAGGGGGGCGCCATGCTCGTCGTCGAGGAGGAGACGGTCGCACGGGGCCGGGAGGCCGCGATCCGGGCCTTCGTCGCCGGGCACGGTGCGACGTTCACCGGCGCGTCCTGCTGGGCGCAGTCCCGGGAGGGTCTGGCGCACGCGATACGCGACGCGCTGAACGAGGCCCGGTGCGCGCCCGAGGAGATCGACGTCGTGTTCGCGGACGCGTTCGGCGTACCGGAGGCCGACCGTGCCGAGGCGCTGGCGATCGCCGACGTCCTGGGCGCACAGGGCCGGCGCGTGCCGGTGACGGCACCCAAGACCGGCATCGGCCGGGCGTACTGCGGAGCGCCGGTGCTGGACGTGGCGGCGGCGGTGCTCGCCATGGAACACGGTCTCGTACCGCCCACCCCGAACGTCTTCGACCCCTGCTACGACCTCGACCTGGTGACCGGGAGCGCTCGCCCCGCCGAGCTGCGCACGGCGCTGGTCCTCAGCCGGGGACTCATGGGCTCGAACGCAGCGCTGGTGCTGCGGCACGGCGCTCATGCCCTCTCATGA	MKPQQKRRAAITGIGVVAPNGLSTETFWKSTEKGLCVLDRVTREGCDHLPLRIAGEVRGFDPVALIEERFLVQTDRFTHFAMAAADLALEDARLGRTYTGDEPFGIGVVTAAGSGGGEFGQRELQRLWGQGPRFVGPYQSIAWFYAASTGQISIRGGFKGPCGVVASDEAGGLDALAHAARAVRRGTDVVVAGAAEAPLAPYSMVCQLGYEDLSTSDDPACAYRPFTGAACGFVPAEGGAMLVVEEETVARGREAAIRAFVAGHGATFTGASCWAQSREGLAHAIRDALNEARCAPEEIDVVFADAFGVPEADRAEALAIADVLGAQGRRVPVTAPKTGIGRAYCGAPVLDVAAAVLAMEHGLVPPTPNVFDPCYDLDLVTGSARPAELRTALVLSRGLMGSNAALVLRHGAHALS	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	100.00	gnl|BL_ORD_ID|1968|hsp_num:0	1943			309	1239	isoniazid
BGC0000271.1|Spore_7 # 6923 # 7180 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.678	BGC0000271.1|Spore_7 	6923	7180	+	Loose	800	22.7126	APH(4)-Ib	27.91	3002656	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(4)	ATGGACAACCAACTGACCGTCCAGGAGCTGGCCGCTCTGATGAAGAAGGCGGCCGGCGTCACGGTGGACGTGAAGGAGCTGGAGGACCGGCTCGACTCCGGCTTCGCCGAGTTCGGGCTCGACTCGCTCGGCCTGCTGGGCATCGTCGGGGAGCTGGAGAACGGCCACGGCGCGGTGCTTCCCCCCGACGCGGAGCGCTGCCGGAACCCGCGCGAGTTCCTCGACCTCGTCAACAACAACATCGTCGCTGGAGCCTGA	MDNQLTVQELAALMKKAAGVTVDVKELEDRLDSGFAEFGLDSLGLLGIVGELENGHGAVLPPDAERCRNPREFLDLVNNNIVAGA	MLQTSKKKSGHDESWANADAHKWRGERKRDNRKIVLSGTTKLLFVAEEQFQLIPPPSYCVSLVPKLPSNVTQPLFEYCFAPRILFFYALKKMTQHTKLCKLSSLIWREMWAISSRLQWQCVCAARRITMRNGGWKFIEMLSCWSDMVHKHESVLISTLPSFINFLVGPFRSAGAEPGGMHRRVDPPRPLSPALIEAFDGVMQLSGAPSRGVTPTPRGPDALGRITDSRGGSEAGYRFNMCNRAVPSAALPIGEVLDIGEFSGKRTYLAAVHRAREQDLPETELPAVLQPCTGMAHAIAAADLSHTSGFAPFGPQGMGQETPWRDKRDCYFDPQVYYWLSQMGDTLRASVAQGFEKRMLWAEDCPEARHLRIHVKGSNAALPEPGPKTWAGDGSQAVWAGRLRPTQDSRYVVASIFPWRPW	20.24	gnl|BL_ORD_ID|1547|hsp_num:0	1681			822	951	hygromycin B
BGC0000271.1|Spore_8 # 7182 # 7661 # 1 # ID=1_8;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.644	BGC0000271.1|Spore_8 	7182	7661	+	Loose	500	25.409	FomA	50.0	3000423	protein homolog model	n/a	n/a	phosphonic acid antibiotic	antibiotic inactivation	Fom phosphotransferase family	GTGTCTGGACACACCGAGAACGACATCATCATCGCCGCCCCCCTGGACCTCGTCTGGGACATGACCAACGACATCGAGAGCTGGCCGCAGCTGTTCAGCGAGTACGCGTCCGTCGATGTCCTGAGCCGGGAGAACGGCACGACCACCTTCCGCCTCACCATGCACCCGGACGAGAACGGCAAGGTCTGGAGCTGGGTCTCGGAACGGACGCCCGACCGGGAGAAGCTGACGGTCACGGCCCGCCGCGTCGAGACCGGCCCCTTCGAGTACATGAACATCAGGTGGGTGTACTCGCAGACCCCCGACGGCACCAGGATGCACTGGACGCAGGACTTCGCGATGAAGCCCGAAGCTCCCGTCGACGACGCCTGGATGACCGACAACATCAACCGCAACTCGGTCGTCCAGATGGAACTCATCCGGGACAAGGTCGAACAGCACGCCCGCGAGCGCAGGACCGCTTCCGTCACCACCGACTGA	MSGHTENDIIIAAPLDLVWDMTNDIESWPQLFSEYASVDVLSRENGTTTFRLTMHPDENGKVWSWVSERTPDREKLTVTARRVETGPFEYMNIRWVYSQTPDGTRMHWTQDFAMKPEAPVDDAWMTDNINRNSVVQMELIRDKVEQHARERRTASVTTD	MTPDFLAIKVGGSLFSRKDEPGSLDDDAVTPFARNFARLAETYRGRMVLISGGGAFGHGAIRDHDSTHAFSLAGLTEATFEVKKRWAEKLRGIGVDAFPLQLAAMCTLRNGIPQLRSEVLRDVLDHGALPVLAGDALFDEHGKLWAFSSDRVPEVLLPMVEGRLRVVTLTDVDGIVTDGAGGDTILPEVDARSPEQAYAALWGSSEWDATGAMHTKLDALVTCARRGAECFIMRGDPGSDLEFLTAPFSSWPAHVRSTRITTTASA	59.77	gnl|BL_ORD_ID|188|hsp_num:0	206			414	462	fosfomycin
BGC0000271.1|Spore_9 # 7741 # 8067 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.700	BGC0000271.1|Spore_9 	7741	8067	+	Loose	750	25.7942	tet(51)	30.19	3004586	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	ATGCACCAAGCCCTGATCGTGGCCCGGATGGCGCCGGGTTCGGCCCCGGACATCGCGAAGGTGTTCGCGGAGTCCGACAGCGGCGAACTGCCGCACCTCGTGGGCGTCACCCGCCGCACCCTGTTCCAGTTCAACGACGTGTACATGCACCTGGTGGAGGCGGACCGGCCGCCCGGCCCCGCGATCGCCGAGGTGGCCGGCCACCCGGCCTTCCGGGACATCAGCGACAGGCTCTCCACCTACGTGAGCGCGTACGACCCGACGACGTGGCGCAGCCCGAAGGACGCGATGGCCCAGGAGTTCTACCGCTGGGAACGCGAGAGCTGA	MHQALIVARMAPGSAPDIAKVFAESDSGELPHLVGVTRRTLFQFNDVYMHLVEADRPPGPAIAEVAGHPAFRDISDRLSTYVSAYDPTTWRSPKDAMAQEFYRWERES	MPIINKILVIGAGIAGPAVCYWLRRFGFSPILVERCANLRKGGHAVDIRGVAIDLAKSMGIYKKICNMRTQVELGRYVDAEGNILHEEKGERFGFREGDDIEILRGDLVQILIDAMGDVPCHFNQWVESIKQRDNDVEVQFKDGRTELYDLVIGADGLHSTTRRMVFDKDEYKLTNLGAYFSAFSIPNYLNLNHTDVQFEANQKLISMASDKNPKIAITGFCFRAQNVLNNLRDENEQRRFLRDTFQDFGWETSKILELMSDSNDFYFDSFTQVKMKSWTKGRVALVGDAGYCASPFPGQGSNQALVGAYIFAGELKQAEGNYHRAFNRYNELLQPFVEANQKFGVLVNESFLVRDEVSKEVAEERSNKIMQEIKIVSNMISLPNYE	27.91	gnl|BL_ORD_ID|2723|hsp_num:0	3288			891	1050	tetracycline; oxytetracycline
BGC0000271.1|Spore_10 # 8101 # 9135 # -1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.692	BGC0000271.1|Spore_10 	8101	9135	-	Loose	500	39.6614	chrB	47.73	3001302	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	ATGACCACAGTGAGTCCCGCCCCCCAGCCGGCCCCGGCCATGCAGCTGAGGGAGCTCGTCTTCGGGGCGGCGTGCGCCGCGGCCGTCCGGGCGGCGGCCAAGCTCGGCGTCGCCGACGCGCTCGGCGAGAAGCCCGCCACCGCGGAAGAACTCGCGGCCGTGCTGGGCACCGAGCCGCGGCCCCTGCTGAGGCTGCTCCGGGCCCTGTCCTGCTACGGCATCTTCGCGCAGAACGACGACGGACGGTTCGTCCACACCAGCATGTCCCGGCTGCTGCGCGAAGACGATCCGCACAGCCTTCGGTACATCTCCCTCTGGTGCACCGAACCCTGGACCTGGGACGCCTGGCCGCGGCTCGACGAGGCGGTGCGGTCGGGCGGCAGCGTCTTCCACGAGCTGTACGGCAAGGGGTTCTTCGACTACCTGCACGAGGACGCGCACGACTCCGCCCAGGTCTTCAACCAGGCCATGACCACGTCCAGCGAGCAGTCGGCGCGGGACGTCGCGGAGCTCCTCGACCTGACCGGCGTGTCGACGGTCGCCGACATCGGCGGCGGCCAGGGACATGTGCTCGCCAGCCTGCTGGAGAAGCACCCGGACATCCGGGGAACCCTGCTCGACCTGCCCCGCGTGGTGGAGAAGGCGGACCCCCGGCTGCGTGACGGCGGCCCGCTCGCCGCGCGGGCCCGGATCGTCGGCGCGGACTGCCGCGAGGAGATCCCGGTCGAGGCCGACCTGTACATCATCAAGAACATCCTGGAATGGGACGACGACAGCACCCGCAGAACCCTGCGGAACGTGATGACGAAGGCCCGCCCCGGAGCCAGGGTCGTCATCATCGAGAACCTCGTCGACGACACCCCGTCGATGAAGTTCACCACGTCCATGGACCTGATGCTGCTCCTCAACGTCGGAGGAGCCAAGCACACCAAGGAAAGCCTGGTCACCCGCATGACGGAGGCCGGTCTGACCGTCGGTGAGATCCGGCCGGTCAACGCGTACCTGCACGCGTTCGAATGCACCGTACCTGCCTGA	MTTVSPAPQPAPAMQLRELVFGAACAAAVRAAAKLGVADALGEKPATAEELAAVLGTEPRPLLRLLRALSCYGIFAQNDDGRFVHTSMSRLLREDDPHSLRYISLWCTEPWTWDAWPRLDEAVRSGGSVFHELYGKGFFDYLHEDAHDSAQVFNQAMTTSSEQSARDVAELLDLTGVSTVADIGGGQGHVLASLLEKHPDIRGTLLDLPRVVEKADPRLRDGGPLAARARIVGADCREEIPVEADLYIIKNILEWDDDSTRRTLRNVMTKARPGARVVIIENLVDDTPSMKFTTSMDLMLLLNVGGAKHTKESLVTRMTEAGLTVGEIRPVNAYLHAFECTVPA	MLNRIVRYLACPHCGASLAQGDRALFCPAGHSFDIAKQGYVNLLPRATKLRADTKEMVEARDAFLSAGHYDPVMDALVDLARRTADPAVPGCVVDIGGGTGHYHAGVMEAFPDAQGLLLDISKYAVRRAAKAHPRIAAAVTDAWQTLPLRDAAAGMVINTFAPRNGPELHRVLHPRGVLLVVTPLPDHLREVIGALGLLQVDEGKESRLAEQLAPHFSAVATEELTRTMALDHQALAHLVGMGPNAWHRDAQRDLETIQRLPAPTRVTLSVRLSAYRLSA	122.86	gnl|BL_ORD_ID|274|hsp_num:0	305			276	408	tylosin; chalcomycin; mycinamicin
BGC0000271.1|Spore_11 # 9182 # 10240 # -1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=3Base/5BMM;rbs_spacer=13-15bp;gc_cont=0.653	BGC0000271.1|Spore_11 	9182	10240	-	Loose	575	28.4906	CblA-1	25.41	3002999	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	CblA beta-lactamase	ATGAACAAAAAAGATTTCGCATACCTCGGTTGCGCCGCAATCGTGGTGGCGTCGGGACTGAGCTGTATCCCGGCGGCCAATGCCGCGACTGCTCATGTCGTGCATCCGGGGGAATCGATCCAGAAAGCGGTCGATGCCGCGCAGTCGGGCGACACCATTGTCATCTCGCCCGGCACCTACCATCAGAGCGTCCTCGTCACGAAGTCCGGTCTGACCATCCGCGGGGCGGGGGAGCGGACCGTGCTGATGCCGGCGGCGACCAGGGCCGCCGACAAGTGCGCGGCCGCCGGCAACGGGATCTGCGTCGAGGGCACGTCCGCCCACCCCGTCACGCGTACCAGCGTCCGCTCGCTCACGCTGACCGGCTACAAGAAGAACGGCCTGTGGGCGTCCAACACCGACAAGCTGACCGTGCGGGACGTGGCCGCAGACAAGAACAAGAACTGGGGCATCGCCATCGAGCGGTCCGTCCGGAGCGTGCTCGAGGAAAACGTCGCCCGGGGAAACGCCGAGTCGGGCGTGTTCCTCTCCAACACGGTGGACACCGAGGCCGGCGCCACGGACACGCGGGGCACCGTCGTCCGCCACAACAGGCTGGAGGGCAACCGGATCGGACTCACCGTCAGGCGTCTGCGGAATGTCACCGTCGAGGAGAACGAACTCAGCGCGAACTGCAGCGGGCTGTTCGCCGTAGGCGACGAGGGCAAGCCGCACGCCGGAGCCCTGGCCATTCGGGGCAATGGCGTCCACGAGAACAACAAATACTGCGCGAAGACGGCTCGGCTGCCCTACATCCAGGGGTCCGGAATTGTTCTCACCGGTACCGAGGACACGGTCGTGGAGTACAACGACATCCGAGACAACGTGGGCAAGTCCGTGTTCTCCGGCGGAGTGGTGCTGTACAAGAGCTTCGTCGGCACGCCGAACAAGCGCAATGTCATCCGGGACAACGTGCTGTCGGGTAATTCGACGGCCGACCTGGCCAACCGGGACACCGGCACCGGCAACAAGTTCGAGCACAACTCGTGTCAGCGCTCCGAACCCGCGGGCATGTGCTGA	MNKKDFAYLGCAAIVVASGLSCIPAANAATAHVVHPGESIQKAVDAAQSGDTIVISPGTYHQSVLVTKSGLTIRGAGERTVLMPAATRAADKCAAAGNGICVEGTSAHPVTRTSVRSLTLTGYKKNGLWASNTDKLTVRDVAADKNKNWGIAIERSVRSVLEENVARGNAESGVFLSNTVDTEAGATDTRGTVVRHNRLEGNRIGLTVRRLRNVTVEENELSANCSGLFAVGDEGKPHAGALAIRGNGVHENNKYCAKTARLPYIQGSGIVLTGTEDTVVEYNDIRDNVGKSVFSGGVVLYKSFVGTPNKRNVIRDNVLSGNSTADLANRDTGTGNKFEHNSCQRSEPAGMC	MKAYFIAILTLFTCIATVVRAQQMSELENRIDSLLNGKKATVGIAVWTDKGDMLRYNDHVHFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMPPNTYSPLRKKFPDQDFTITLRELMQYSISQSDNNACDILIEYAGGIKHINDYIHRLSIDSFNLSETEDGMHSSFEAVYRNWSTPSAMVRLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAKTVVGHKTGSSDRNADGMKTADNDAGLVILPDGRKYYIAAFVMDSYETDEDNANIIARISRMVYDAMR	118.92	gnl|BL_ORD_ID|0|hsp_num:0	2			531	876	cephaloridine
BGC0000271.1|Spore_12 # 10486 # 11118 # -1 # ID=1_12;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.738	BGC0000271.1|Spore_12 	10486	11118	-	Loose	375	43.5134	Escherichia coli AcrAB-TolC with AcrR mutation conferring resistance to ciprofloxacin, tetracycline, and ceftazidime	37.25	3003807	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic target alteration; antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGAGCGAGACGACGAAGACGAAGCTCCTCGAAGGAGCGCTGCGGGCGCTCTCCGAGCAGGGGATCGCCAAGACGTCCGCCCGTGCGATCGCCGCGGCCGCCGGAGTCAACCAGGCGCTCGTCTTCTACCACTTCGGATCGGTGGACGAACTGCTGGCCGCGGCCTGCCGGCACGGCGCAGAGCAGGTGGTGGCGCGCTACCGGGCACGGCTGGACGAGGTCGCCACCCTGGCCGAGCTCCTCGCGCTGGGCCGCGAGCTGCACGAGCAGGAGAAGGCCGAGGGCCATGTGGCGATGCTCGGCCAGCTGCTCGCCGGCGCCCAGACGCAGCCACGCCTCGCACCCGCGACGGCGGCCGGCCTCGACCTCTGGATCGCGGAGATCGAGAAGGTGCTGACCCGCGTCCTGACCCCGACCCCGCTGGGCGAGTTCGCCGACCCGGCGGGGCTGGCGCGGGCGGTGGCGGCGTCGTTCGTGGGGATCGAGCTGTACGAGGGGGTGGACGCGGAAGGGGCCGGGGCCGCCCTCGCGGCACTGGACCAATTGGCACTCCTGCTGACGGCGTTGGAGGACCTGGGCCCGGTCGCCCAGCGCGCGGTCCGCCACACCCTGCGCCGGGCCACCCGCGGCTGA	VSETTKTKLLEGALRALSEQGIAKTSARAIAAAAGVNQALVFYHFGSVDELLAAACRHGAEQVVARYRARLDEVATLAELLALGRELHEQEKAEGHVAMLGQLLAGAQTQPRLAPATAAGLDLWIAEIEKVLTRVLTPTPLGEFADPAGLARAVAASFVGIELYEGVDAEGAGAALAALDQLALLLTALEDLGPVAQRAVRHTLRRATRG	MARKTKQEAQETRQHILDVALRLFSQQGVSSTSLGEIAKAAGVTRGAIYWHFKDKSDLFSEIWELSESNIGELELEYQAKFPGDPLSVLREILIHVLESTVTEERRRLLMEIIFHKCEFVGEMAVVQQAQRNLCLESYDRIEQTLKHCIEAKMLPADLMTRRAAIIMRGYISGLMENWLFAPQSFDLKKEARDYVAILLEMYLLCPTLRNPATNE	97.67	gnl|BL_ORD_ID|2090|hsp_num:0	2306			27	180	tigecycline; ciprofloxacin; tetracycline; ceftazidime; rifampin; chloramphenicol; ampicillin; cefalotin; triclosan
BGC0000271.1|Spore_5 # 4394 # 5659 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.700	BGC0000271.1|Spore_5 	4394	5659	+	Loose	750	210.69	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	37.73	3003463	protein variant model	F413L	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	ATGACCCGGCGCGTGGCGGTCACCGGCGTCGGCATCGTCGCCCCGGGCGGTGTGGGCGTCCCGGCGTTCTGGGACCTCCTGGCGAACGGCCGCACCGCGACGAGGGGCATCACGCTCTTCAACCCGGAAGGTCTGCGTTCGCGTATCGCGGCCGAGTGCGACTTCGACCCGGCCGCCCACGGAATCGACGCGGCGGCCGCTGAGCGCGCCGACCGCTATGTCCAGTTCGCCATGGTCGCCGCCAGGGAGGCGGTGGGCGACGCGGGACTCGGCCCGGAGAAGGAAGACCCCTGGCGCATCGGGGTGTCCCTGGGCACCGCCGTCGGTGGCACCACGCGCCTCGAACACGACTATGTCGCGGTGAGCGAGACCGGCCGGCGGTGGGATGTCGACCACCGCCTGGCCGACCCCCATCTGCACCGCGCGTTCTCACCCAGCACCCTCGCCTCCGAGGTGGCCGAACAGTTCGGTGCCCACGGCCCGGTGCAGACCGTCTCCACGGGCTGCACCTCCGGCCTCGACGCGATCGGCTACGCCTTCCACGCCGTACAGGAGGGACGGGTCGACGTGTGCATAGCGGGCGCTTCGGACTCGCCGATCTCACCCATCACGATGGCGTGCTTCGACGCCATCAAGGCGACCTCCCCGAACAACGACGACCCCGAGCACGCGTCCAAGCCGTTCGACAAGCACCGCAACGGGTTCGTCATGGGCGAGGGCGGAGCCGTCCTGATCCTGGAGGAGCTCGAACACGCGCGGGCCCGTGGCGCACGTGTGTACTGCGAGATCGGCGGCTATGCCACCTTCGGCAACGCCTACCACATGACCGGCCTCACCCGTGAGGGTCTGGAGATGGCGCGTGCGATCGACGGCGCCCTCGCGCACGCCCGGTTGGACGGCTCCGACATCGACTACGTCAACGCCCACGGCTCCGGCACCCAGCAGAACGACCGGCACGAGACAGCCGCCGTGAAACGGTCCCTGGGCGACCACGCGTACCGGACGCCGATGAGTTCGATCAAGTCGATGGTGGGCCACTCCCTGGGCGCCATCGGTGCGATCGAGGTCCTGGCCTGCGTCCTGGCTCTCGTCCATCAGGTCGTGCCGCCCACGGCGAACTACACGACCCCGGACCCCGAGTGCGACCTCGACTACGTGCCGCGCACCGCACGGCAGGTCAAACTCCGCAACGTGTTGTCCGTCGGCAGTGGCTTCGGCGGCTTCCAGTCCGCGGTGGTGCTGACCCGCCCAGATGGGAGGACCTGA	MTRRVAVTGVGIVAPGGVGVPAFWDLLANGRTATRGITLFNPEGLRSRIAAECDFDPAAHGIDAAAAERADRYVQFAMVAAREAVGDAGLGPEKEDPWRIGVSLGTAVGGTTRLEHDYVAVSETGRRWDVDHRLADPHLHRAFSPSTLASEVAEQFGAHGPVQTVSTGCTSGLDAIGYAFHAVQEGRVDVCIAGASDSPISPITMACFDAIKATSPNNDDPEHASKPFDKHRNGFVMGEGGAVLILEELEHARARGARVYCEIGGYATFGNAYHMTGLTREGLEMARAIDGALAHARLDGSDIDYVNAHGSGTQQNDRHETAAVKRSLGDHAYRTPMSSIKSMVGHSLGAIGAIEVLACVLALVHQVVPPTANYTTPDPECDLDYVPRTARQVKLRNVLSVGSGFGGFQSAVVLTRPDGRT	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	101.20	gnl|BL_ORD_ID|1968|hsp_num:0	1943			294	1245	isoniazid
